No Evidence of Sustained Myocardial Injury Following an Ironman Distance Triathlon

Abstract

We aimed to determine whether an Ironman distance triathlon resulted in sustained myocardial injury detected by electrocardiography, biochemical markers or echocardiographic assessment of left ventricular systolic and diastolic function. Electrocardiograms, blood for analysis of creatine kinase (CK) and its MB fraction, cardiac troponin I (cTnI) and echocardiograms were obtained in 15 male athletes prior to and at a mean of 4.7 days after competing in the Australian Ironman Triathlon. Regional wall motion scores, left ventricular ejection fraction (LVEF) and mitral inflow parameters were determined from the echocardiograms by a blinded investigator. Levels of cTnI were undetectable in all athletes and total CK was mildly elevated in 7/15 athletes prior to the event. Baseline wall motion, ejection fraction and diastolic filling were normal in all athletes. CK levels were increased post-race (p < 0.05) with a mean post-race level of 451U/l. Levels of cTnI were undetectable post-race in 14 athletes with a level of 0.9 µg/l recorded in one athlete, although all were within the laboratory’s normal range for the assay. Mitral inflow parameters and LVEF did not change post-race and regional wall motion was normal in 14 of 15 athletes. Regional wall motion abnormalities detected in 1 athlete had resolved by 25 days post-race. These findings indicate that ultraendurance exercise does not result in sustained myocardial injury in this group of elite athletes.

Human - endurance exercise - echocardiography - cardiac enzymes

References

• 1 Albert C M, Mittleman M A, Chae C U, Lee I, Hennekens C H, Manson J E. Triggering of sudden death from cardiac causes by vigorous exertion.  N Engl J Med. 2000;  343 1355-1361
• 2 Rifai N, Douglas P S, O’Toole M, Rimm E, Ginsburg G S. Cardiac Troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon.  Am J Cardiol. 1999;  83 1085-1089
• 3 Neumayr G, Gaenzer H, Pfister R, Sturm W, Schwarzacher S P, Eibl G, Mitterbauer G, Hoertnagel H. Plasma levels of Cardiac Troponin I after prolonged strenuous endurance exercise.  Am J Cardiol. 2001;  87 69-71
• 4 Denvir M A, Galloway P J, Meighan A S, Blyth M, Alexander C, Fleming C, Frame F. Changes in skeletal and cardiac muscle enzymes during the Scottish Coast to Coast Triathlon.  Scott Med J . 1999;  44 49-51
• 5 Koller A, Summer P, Moser H. Regular exercise and subclinical myocardial injury during prolonged aerobic exercise [letter].  JAMA. 1999;  282 1816--
• 6 Koller A, Mair J, Mayr M, Calzolari C, Larue C, Puschendorf B. Diagnosis of myocardial injury in marathon runners [letter].  Ann NY Acad Sci. 1995;  752 234-235
• 7 Laslett L, Eisenbud E. Lack of detection of myocardial injury during competitive races of 100 miles lasting 18 to 30 hours.  Am J Cardiol. 1997;  80 379-380
• 8 Bonetti A, Tirelli F, Albertini R, Monica C, Monica M, Tredici G. Serum cardiac troponin T after repeated endurance exercise events.  Int J Sports Med. 1996;  17 259-262
• 9 Sorichter S, Mair J, Calzolari C, Rama D, Puschendorf B, Berg A. Changes in skeletal and cardiac troponin I serum levels in 42 athletes after a sprint marathon.  Int J Sports Med 1996. 17(suppl1) 511--
• 10 Antman E M, Tanasijevic M J, Thompson B, Schactman M, McCabe C H, Cannon C P, Fischer G A, Fung A Y, Thompson C, Wybenga D, Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.  NEJM. 1996;  335 1342-1349
• 11 Donnelly R, Millar-Craig M W. Cardiac troponins: IT upgrade for the heart.  Lancet. 1998;  351 537-542
• 12 Galvani M, Ottani F, Ferrini D, Ladenson J H, Destro A, Baccos D, Rusticali F, Jaffe A S. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina.  Circulation. 1997;  95 2053-2059
• 13 Pluim B M, Zwinderman A H, van der Laarse A, van der Wall E E. The athlete’s heart: a meta-analysis of cardiac structure and function.  Circulation 1999. 100 336-344
• 14 Stromme J H, Johansen O, Brekke M, Seljeflot I, Arnesen H. Markers of myocardial injury in blood following PTCA: a comparison of CKMB cardiospecific troponin T and troponin I.  Scand J Clin Lab Invest. 1998;  58 693-700
• 15 Neumayr G, Pfister R, Mitterbauer G, Maurer A, Gaenzer H, Sturm W, Hoertnagl H. Effect of the “Race across the alps” in elite cyclist on plasma cardiac troponins I and T.  Am J Cardiol. 2002;  89 484-486
• 16 Vasan R S, Larson M G, Benjamin E F, Evans J C, Reiss C K, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction.  J Am Coll Cardiol. 1999;  33 1948-1955
• 17 Dauterman K W, Massie B M, Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity.  Am Heart J.. 1998;  135 310-319
• 18 Persson H, Linder-Klingsell E, Eriksson S V, Erhardt L. Heart failure after myocardial infarction: the importance of diastolic dysfunction. A prospective clinical and echocardiographic study. Eur Heart J.  1995. Apr ;  16 496-505
• 19 Swan H J. Left ventricular systolic and diastolic dysfunction in the acute phases of myocardial ischaemia and infarction, and in the later phases of recovery. Function follows morphology.   Eur Heart J. 1993;  14 Suppl A 48-56
• 20 Chen Y, Serfass R C, Mackey-Bojack S M, Kelly K L, Titus J L, Apple F S. Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged intense exercise.  J Appl Physiol. 2000;  88 1749-1755
• 21 Damm S, Andersson L G, Henriksen E, Niklasson U, Jonason T, Ahren T, Wesslen L, Nystrom-Rossander C, Rolf C, Hedenstierna G, Ringqvist I, Friman G. Wall motion abnormalities in male elite orienteers are aggravated by exercise.  Clin Physiol 1999. 19 121-126